178 related articles for article (PubMed ID: 18645509)
1. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial.
Sarna A; Luchters S; Geibel S; Chersich MF; Munyao P; Kaai S; Mandaliya KN; Shikely KS; Temmerman M; Rutenberg N
J Acquir Immune Defic Syndr; 2008 Aug; 48(5):611-9. PubMed ID: 18645509
[TBL] [Abstract][Full Text] [Related]
2. Implementation of clinic-based modified-directly observed therapy (m-DOT) for ART; experiences in Mombasa, Kenya.
Munyao P; Luchters S; Chersich MF; Kaai S; Geibel S; Mandaliya KN; Temmerman M; Rutenberg N; Sarna A
AIDS Care; 2010 Feb; 22(2):187-94. PubMed ID: 20390497
[TBL] [Abstract][Full Text] [Related]
3. Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.
White BL; Golin CE; Grodensky CA; Kiziah CN; Richardson A; Hudgens MG; Wohl DA; Kaplan AH
AIDS Behav; 2015 Jan; 19(1):128-36. PubMed ID: 25055766
[TBL] [Abstract][Full Text] [Related]
4. Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.
Berg KM; Litwin AH; Li X; Heo M; Arnsten JH
Clin Infect Dis; 2011 Nov; 53(9):936-43. PubMed ID: 21890753
[TBL] [Abstract][Full Text] [Related]
5. Safer sexual behaviors after 12 months of antiretroviral treatment in Mombasa, Kenya: a prospective cohort.
Luchters S; Sarna A; Geibel S; Chersich MF; Munyao P; Kaai S; Mandaliya KN; Shikely KS; Rutenberg N; Temmerman M
AIDS Patient Care STDS; 2008 Jul; 22(7):587-94. PubMed ID: 18601582
[TBL] [Abstract][Full Text] [Related]
6. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
[TBL] [Abstract][Full Text] [Related]
7. Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.
Berg KM; Mouriz J; Li X; Duggan E; Goldberg U; Arnsten JH
Contemp Clin Trials; 2009 Sep; 30(5):481-9. PubMed ID: 19505589
[TBL] [Abstract][Full Text] [Related]
8. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.
Hart JE; Jeon CY; Ivers LC; Behforouz HL; Caldas A; Drobac PC; Shin SS
J Acquir Immune Defic Syndr; 2010 Jun; 54(2):167-79. PubMed ID: 20375848
[TBL] [Abstract][Full Text] [Related]
9. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.
Berg KM; Litwin A; Li X; Heo M; Arnsten JH
Drug Alcohol Depend; 2011 Jan; 113(2-3):192-9. PubMed ID: 20832196
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy.
Nachega JB; Chaisson RE; Goliath R; Efron A; Chaudhary MA; Ram M; Morroni C; Schoeman H; Knowlton AR; Maartens G
AIDS; 2010 Jun; 24(9):1273-80. PubMed ID: 20453627
[TBL] [Abstract][Full Text] [Related]
11. Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil.
Côté J; Delmas P; de Menezes Succi RC; Galano E; Auger P; Sylvain H; Colson S; Machado DM
J Adolesc Health; 2016 Sep; 59(3):305-310. PubMed ID: 27320032
[TBL] [Abstract][Full Text] [Related]
12. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
13. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
14. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
Jayaweera DT; Kolber MA; Brill M; Tanner T; Campo R; Rodriguez A; Chu HM; Garg V
HIV Med; 2004 Sep; 5(5):364-70. PubMed ID: 15369512
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
Macalino GE; Hogan JW; Mitty JA; Bazerman LB; Delong AK; Loewenthal H; Caliendo AM; Flanigan TP
AIDS; 2007 Jul; 21(11):1473-7. PubMed ID: 17589194
[TBL] [Abstract][Full Text] [Related]
17. Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting.
Taiwo BO; Idoko JA; Welty LJ; Otoh I; Job G; Iyaji PG; Agbaji O; Agaba PA; Murphy RL
J Acquir Immune Defic Syndr; 2010 May; 54(1):85-92. PubMed ID: 20418724
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria.
Adejumo O; Oladeji B; Akpa O; Malee K; Baiyewu O; Ogunniyi A; Evans S; Berzins B; Taiwo B
Int J STD AIDS; 2016 Oct; 27(11):938-49. PubMed ID: 26384949
[TBL] [Abstract][Full Text] [Related]
19. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
Muyingo SK; Walker AS; Reid A; Munderi P; Gibb DM; Ssali F; Levin J; Katabira E; Gilks C; Todd J;
J Acquir Immune Defic Syndr; 2008 Aug; 48(4):468-75. PubMed ID: 18614918
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
